Pacer Advisors Inc. Sells 1,229 Shares of Synopsys, Inc. $SNPS

Pacer Advisors Inc. trimmed its stake in shares of Synopsys, Inc. (NASDAQ:SNPSFree Report) by 4.0% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 29,341 shares of the semiconductor company’s stock after selling 1,229 shares during the period. Pacer Advisors Inc.’s holdings in Synopsys were worth $13,782,000 as of its most recent SEC filing.

Several other institutional investors have also added to or reduced their stakes in SNPS. Thurston Springer Miller Herd & Titak Inc. bought a new position in Synopsys during the 4th quarter worth about $28,000. Caitong International Asset Management Co. Ltd acquired a new stake in shares of Synopsys in the 4th quarter valued at about $28,000. Atlas Capital Advisors Inc. bought a new stake in shares of Synopsys in the fourth quarter valued at about $32,000. Kemnay Advisory Services Inc. bought a new stake in shares of Synopsys in the fourth quarter valued at about $35,000. Finally, Oakworth Capital Inc. boosted its position in shares of Synopsys by 3,700.0% during the fourth quarter. Oakworth Capital Inc. now owns 76 shares of the semiconductor company’s stock worth $36,000 after buying an additional 74 shares during the period. 85.47% of the stock is owned by institutional investors.

Insider Buying and Selling at Synopsys

In related news, CEO Sassine Ghazi sold 14,603 shares of the business’s stock in a transaction on Monday, June 15th. The shares were sold at an average price of $458.96, for a total transaction of $6,702,192.88. Following the transaction, the chief executive officer directly owned 75,020 shares in the company, valued at approximately $34,431,179.20. The trade was a 16.29% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CFO Shelagh Glaser sold 3,394 shares of the company’s stock in a transaction on Friday, June 12th. The stock was sold at an average price of $450.02, for a total transaction of $1,527,367.88. Following the sale, the chief financial officer directly owned 14,358 shares in the company, valued at $6,461,387.16. This trade represents a 19.12% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.56% of the stock is currently owned by company insiders.

Synopsys Stock Performance

Shares of NASDAQ SNPS opened at $455.51 on Friday. The stock has a 50 day moving average price of $479.14 and a 200 day moving average price of $462.05. Synopsys, Inc. has a 52 week low of $376.18 and a 52 week high of $651.73. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.32 and a current ratio of 1.43. The stock has a market capitalization of $87.22 billion, a PE ratio of 105.44, a price-to-earnings-growth ratio of 2.68 and a beta of 1.22.

Synopsys (NASDAQ:SNPSGet Free Report) last posted its quarterly earnings results on Wednesday, May 27th. The semiconductor company reported $3.35 earnings per share for the quarter, topping the consensus estimate of $3.15 by $0.20. Synopsys had a return on equity of 5.83% and a net margin of 8.91%.The firm had revenue of $2.28 billion for the quarter, compared to analyst estimates of $2.25 billion. During the same quarter in the previous year, the firm earned $3.67 EPS. The business’s quarterly revenue was up 41.9% on a year-over-year basis. Synopsys has set its FY 2026 guidance at 14.720-14.800 EPS and its Q3 2026 guidance at 3.630-3.690 EPS. Analysts predict that Synopsys, Inc. will post 10.65 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of research analysts recently issued reports on the company. Robert W. Baird set a $558.00 price objective on Synopsys in a report on Thursday, May 28th. Bank of America upped their price target on Synopsys from $515.00 to $600.00 and gave the stock a “buy” rating in a research report on Thursday, May 28th. Rosenblatt Securities raised their price target on shares of Synopsys from $530.00 to $575.00 and gave the stock a “buy” rating in a research note on Tuesday, May 26th. Citigroup boosted their price objective on shares of Synopsys from $600.00 to $610.00 and gave the stock a “buy” rating in a research report on Thursday, May 28th. Finally, Morgan Stanley increased their target price on shares of Synopsys from $480.00 to $525.00 and gave the stock an “equal weight” rating in a report on Thursday, May 28th. Nine equities research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Hold” and a consensus price target of $563.81.

Get Our Latest Analysis on Synopsys

About Synopsys

(Free Report)

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.

Recommended Stories

Institutional Ownership by Quarter for Synopsys (NASDAQ:SNPS)

Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.